News Story: PharmaDoctor announce collaboration with The Encephalitis Society, their new official charity partner.
Analysis: PharmaDoctor have teamed up with The Encephalitis Society to help raise awareness of the dangerous condition and ensure at risk travellers have access to convenient and reliable travel health clinics.
Article published on the 22-02-2019
PharmaDoctor and the Encephalitis Society announce a partnership to improve public awareness of encephalitis and improve access to convenient, clinically robust travel health services to help protect UK travellers.
LONDON – PharmaDoctor (owned by Escripts Marketing Ltd), and the Encephalitis Society (Registered Charity No. 1087843) are pleased to announce a long-term partnership whereby PharmaDoctor becomes the official sponsor of the Encephalitis Society’s online travel health guidance portal.
The Encephalitis Society is launching a new section on its website to increase travellers’ awareness of infectious disease risks when travelling abroad, including Japanese encephalitis, tick-borne encephalitis and rabies.
PharmaDoctor will give website visitors access to a free personalised online travel health consultation with details of an independent, nation-wide network of convenient pharmacy-based travel clinics, where users can receive further advice and vaccinations when protection is required.
The partnership announced today will enable both PharmaDoctor and the Encephalitis Society to support each other’s shared objective of raising the awareness of encephalitis and helping travellers receive comprehensive, clinically accurate travel health advice and protection.
''I am delighted that the Encephalitis Society is becoming PharmaDoctor's official charity partner” commented Graham Thoms, Chief Executive of PharmaDoctor. ''Not only will we be donating a significant percentage of our sales to the Society, we shall also be working hard to raise awareness of encephalitis, a condition which affects 500,000 people globally. Patients who go onto the Encephalitis Society website will benefit from a free online travel health risk-assessment and access to PharmaDoctor’s convenient travel clinic network, the largest of its kind in the UK”.
Commenting on the new partnership with PharmaDoctor, Chief Executive Officer at The Encephalitis Society, Dr Ava Easton, says: ''We are delighted with our new collaboration with PharmaDoctor. Raising funds and public awareness is the mainstay of the Society’s work. This partnership allows us to take a step further by offering our supporters an innovative and pragmatic way of addressing their travel healthcare needs”.
For more information on the joint PharmaDoctor-Encephalitis Society partnership, please visit the respective PharmaDoctor and Encephalitis Society websites:
Notes to Editors
PharmaDoctor is owned by eScripts Marketing Limited, an Independent Medical Agency, registered with the Care Quality Commission and the Regulation and Quality Improvement Authority.
PharmaDoctor was originally set up in 2009 to provide an online doctor service for pharmacies. To this, the company added a new generation of services for pharmacy to become the leading provider of clinically supported private Patient Group Directions (PGDs).
In 2015, PharmaDoctor introduced the first fully integrated Clinical Service Packages for pharmacies, including innovative digital consultation platforms with integrated PGDs (eTool©), Test ‘n Treat PGD packages and pharmacist training.
About the Encephalitis Society
WORLD ENCEPHALITIS DAY
World Encephalitis Day (www.worldencephalitisday.org) on February 22 is the global awareness day for people who have been directly or indirectly affected by encephalitis.
Founded by The Encephalitis Society in 2014, it has reached more than 100 million people in the past six years through media features, events and social media.
THE ENCEPHALITIS SOCIETY
The Encephalitis Society was founded in 1994, is a registered charity and the only resource of its kind in the world providing direct support and information to people affected by encephalitis, and to their family and friends.
The Encephalitis Society receives no Government funding and relies on income raised from individuals, businesses and grant-making organisations.
Encephalitis (noun, /ɛnˌkɛfəˈlʌɪtɪs/) is inflammation of the brain and is caused either by an infection invading the brain (infectious); or through the immune system attacking the brain in error (post-infectious / autoimmune encephalitis).
The condition is indiscriminate, striking adults and children alike, showing no respect for age, gender, or ethnic origin.
Mortality rates are high and in those who survive many are left with an acquired brain injury, the degree and severity of which will vary. Their difficulties may include cognitive, physical, emotional, behavioural, or psychosocial consequences.
The types of symptoms seen in encephalitis reflect the specific areas of the brain affected by the inflammation. The range of symptoms and their rate of development vary widely and can make the diagnosis of encephalitis difficult.
Infectious encephalitis frequently begins with a ‘flu-like illness or headache. Typically more serious symptoms follow hours to days later. The most serious finding is an alteration in level of consciousness. This can range from mild confusion or drowsiness, to loss of consciousness, seizures and coma. Other symptoms include a high temperature, seizures (fits), aversion to bright lights, inability to speak or control movement, sensory changes, neck stiffness, or uncharacteristic behaviour.
In autoimmune types of encephalitis people can present with psychosis and hallucinations among other neurological presentations. Sometimes these patients can be mistakenly thought to be developing psychiatric or mental health illnesses.
For all enquiries relating to this press release, please contact:
Graham Thoms, Chief Executive Officer, PharmaDoctor
Email: firstname.lastname@example.org; Direct: 07494 469433 / 0203 176 0022 (option 1)
Julia Clark, Director of Income Generation
Email: email@example.com Direct: 01653 692583